Friday, June 2, 2017

Nicotine normalizes brain deficits key to schizophrenia - NEUROSCIENCE

A steady stream of nicotine normalizes genetically-induced impairments in brain activity associated with schizophrenia, according to new research involving CU Boulder researchers. The finding sheds light on what causes the disease and why those who have it tend to smoke heavily.

Ultimately the authors of the study, published in the journal Nature Medicine, envision their work could lead to new non-addictive, nicotine-based treatments for some of the 51 million people worldwide who suffer from the disease. It could also potentially have applications for treating addiction, Attention Deficit Hyperactivity Disorder, Bipolar disorder and other psychiatric conditions.

Journal article:


No comments:

Post a Comment